• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
HYD
Click for more information
8.33% 1.3¢

HYDRIX LIMITED

Market Cap $3.559M  ! watchlist Created with Sketch. Add to my watchlist

Hydrix Limited is an Australia-based specialist product designing, engineering and... Hydrix Limited is an Australia-based specialist product designing, engineering and medical device distribution company. The Company is engaged in the development of comprehensive products. Its segments include Hydrix Services, Hydrix Medical and Hydrix Ventures. Hydrix Services segment offers a comprehensive range of engineering, development and regulatory consulting services, including software, electronics, mechanical, industrial design and general product development services. Hydrix Medical distributes disruptive cardiovascular technologies that address unmet needs of patients and healthcare providers. Products include the Guardian real-time heart attack warning system from Avertix Medical, Implicity’s cloud-based artificial intelligence (AI)-driven remote cardiac patient monitoring and data management solution, and Echo IQ’s AI technology. Hydrix Services segment’s portfolio companies include Gyder Surgical Pty Ltd, Avertix Medical Inc., Memphasys Limited, and Cyban Pty Ltd.More

Latest Threads

Tag Subject Date Created with Sketch. Comments Created with Sketch. Views Created with Sketch.
HYD
Ann: Annual General Meeting and Director Nomination Closing Date 		19/09/24 0 1
19/09/24 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  1 
HYD
Client funding - miner 		13/03/19 4 3.6K
13/03/19 Last post  Dabru Comments Created with Sketch.  4  Views Created with Sketch.  3.6K 
HYD
Brand new to stocks. How do i even start? 		05/03/19 4 2.0K
05/03/19 Last post  Nutsy Comments Created with Sketch.  4  Views Created with Sketch.  2.0K 
HYD
solid - next cochlear in the making 		02/03/19 4 1.7K
02/03/19 Last post  peejay2 Comments Created with Sketch.  4  Views Created with Sketch.  1.7K 
HYD
Ann: Appendix 4D and Half-Yearly Report 		17:37 0 284
17:37 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  284 
HYD
News: HYD Hydrix Posts 2Q19 Revenue Of $3.1 Mln 		31/01/19 0 545
31/01/19 Last post  Hot News Comments Created with Sketch.  0  Views Created with Sketch.  545 
HYD
Ann: Appendix 4C - quarterly 		31/01/19 0 397
31/01/19 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  397 
HYD
Ann: Change in substantial holding 		19:32 21 6.2K
19:32 Last post  tombo Comments Created with Sketch.  21  Views Created with Sketch.  6.2K 

See All Discussions arrow Created with Sketch.

Timeline

Annual General Meeting and Director Nomination Closing Date
19 Sep 14:40
 
(20min delay)
Last
1.3¢ 		Change
0.001(8.33%) 		Mkt cap ! $3.559M
Open High Low Value Volume
1.3¢ 1.3¢ 1.3¢ $3.005K 231.1K

Buyers (Bids)

No. Vol. Price($)
1 965180 1.2¢
 

Sellers (Offers)

Price($) Vol. No.
1.3¢ 7466 1
View Market Depth
Last trade - 14.20pm 27/09/2024 (20 minute delay) ?
Last
1.3¢ 		  Change
0.001 ( 8.33 %)
Open High Low Volume
1.3¢ 1.3¢ 1.3¢ 7466
Last updated 15.58pm 27/09/2024 ?
HYD (ASX) Chart

Top Stories

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Coda Minerals (ASX:COD) CEO, Chris Stevens, joins The Market Online to discuss the company's current rights issue, and how the capital from this raise will be used to further its copper exploration in South Australia. In addition, Chris talks through the journey the company has taken over the last few years since listing until now.
5.6g/t gold intercept at Serbia's Rogozna supports Strickland's hopes for high-grade core Strickland Metals Ltd has found an extensive zone of high-grade gold and base metals mineralisation at its Rogozna project
ACCC seeks Olam divestments before it can buy Namoi Cotton Australia's market regulator the ACCC has expressed further concerns about the potential takeover of Namoi Cotton by Olam Agri.
Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals Actinogen Medical is developing a promising oral treatment for Alzheimer's and depression and is accelerating clinical trials with new capital.
Week 39 Wrap: What HotCopper’s watching; China’s new stimmy moves boost metals; Oz CPI drop What HotCopper users were watching; China outshines USA's Fed cut; Oz inflation CPI tracks downwards & more!
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.